Sleep apnea oral appliances market to reach $746.6m by 2029

Thanks to an increased awareness of the serious impacts of untreated sleep apnea.

The global sleep apnea oral appliances market is projected to rise from $471.2m in 2024 to $746.6m by 2029, at a compound annual growth rate of 9.6%, said MarketsandMarkets.

The sector’s growth is primarily attributed to an increased awareness of the serious impacts of untreated sleep apnea and expanding opportunities in emerging markets.

The mandibular advancement devices segment currently leads the market, attracting consumers looking for less intrusive alternatives to CPAP therapy.

“Key players, including ResMed and ProSomnus, are actively enhancing their offerings through strategic acquisitions and innovations, contributing to a competitive landscape that seeks to meet the diverse needs of sleep apnea patients,” the report said.

By purchase type, physician-prescribed/customised oral appliances held the majority share of the market in 2023, attributed to their high levels of patient comfort and customisation.